SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)

$8.874 -0.496 (-5.2935%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 60

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) News Sources

Middle East Outlook Rattles Asian Stock Markets

02-04-2026

yahoo.com

Geopolitics, Beijing Regulatory Changes Lift Asian Stock Markets

20-04-2026

yahoo.com

Assessing Sumitomo Pharma (TSE:4506) Valuation After A Strong Year And Recent Share Price Pullback

06-05-2026

yahoo.com

Japan Regenerative Medicine Market Trends and Forecasts to 2035 Featuring Astellas Pharma, Fujifilm, JCR Pharmaceuticals, Sumitomo Pharma, Takeda, and Terumo

13-05-2026

yahoo.com

New Data from Sumitomo Pharma America at AUA 2026 Highlight Efficacy of Vibegron in Men Aged 75 and Older with Overactive Bladder and BPH

18-05-2026

yahoo.com

Poxel Reports First Quarter 2026 Revenue and Provides a Business Update

20-05-2026

yahoo.com

Sumitomo Pharma America Presents First Clinical Data for SMP-3124LP, an Investigational PEGylated Liposome CHK1 Inhibitor, at ASCO 2026

01-06-2026

yahoo.com

Generalized Anxiety Disorder Market Forecast Shows Strong CAGR During the Forecast Period (2026-2036) Driven by Innovative Therapies | DelveInsight

04-06-2026

yahoo.com

Sumitomo Pharma America Achieves Key Patient Enrollment Milestone for Pivotal Phase 2 Study of Enzomenib in the Treatment of Relapsed/Refractory Acute Leukemia

10-06-2026

yahoo.com

Sumitomo Pharma America Announces Encouraging Clinical and Translational Data at EHA 2026, Highlighting Investigational Combination Therapy in Relapsed/Refractory Myelofibrosis and New Research Findings in Menin Inhibition in Leukemia

15-06-2026

yahoo.com

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) Sentiment Trend

0 25 50 75 100 17 47 49 77 67 74 77 68 62 60 02-04-2026 20-04-2026 06-05-2026 13-05-2026 18-05-2026 20-05-2026 01-06-2026 04-06-2026 10-06-2026 15-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) FAQs

toggle

What is the current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The current price of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is $8.874.


toggle

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is $-0.496.


toggle

SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) since the previous trading day is -5.2935%.


toggle

What is the most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The most recent average sentiment score for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is 60 out of 100.


toggle

What is the most recent average sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)?

The most recent sentiment for SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS) is .


SEC-8K** Filing Available For SUMITOMO PHARMA CO LTD (DNPUF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.